• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在弗雷明汉后代研究中,晚期糖基化终末产物受体(RAGE)基因Gly82Ser多态性与心血管疾病无关。

The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.

作者信息

Hofmann Marion A, Yang Qiong, Harja Evis, Kedia Prashant, Gregersen Peter K, Cupples L Adrienne, Schmidt Ann Marie, Hudson Barry I

机构信息

Division of Surgical Science, Department of Surgery, College of Physicians and Surgeons, Columbia University, 630 W 168th Street, P and S 17-401, New York, NY 10032, USA.

出版信息

Atherosclerosis. 2005 Oct;182(2):301-5. doi: 10.1016/j.atherosclerosis.2005.02.006.

DOI:10.1016/j.atherosclerosis.2005.02.006
PMID:16159602
Abstract

The receptor for advanced glycation end-products (RAGE) is expressed to enhance degrees in human atherosclerotic plaques and co-localizes with inflammatory and pro-oxidant mediators in the vulnerable regions of the plaque. Previous studies highlighted a number of variants in the gene encoding the receptor, including a Gly to Ser substitution at amino acid 82 within the ligand-binding domain of RAGE. The Ser82 allele enhanced ligand-binding affinity and increased ligand-stimulated generation of inflammatory mediators in transfected cells and human monocytes compared to the common RAGE Gly82 allele. Thus it was logical to test the hypothesis that increased prevalence of the Gly82Ser polymorphism was associated with cardiovascular events in the Framingham offspring study (n=1632). Our analyses revealed that the Gly82Ser RAGE polymorphism did not demonstrate any association with the incidence of cardiovascular disease in diabetic or non-diabetic subjects (Gly82 96%, Ser82 4%). Analysis of specific manifestations of cardiovascular disease, including coronary heart disease (CHD), cardiovascular disease (CVD), myocardial infarction (MI) and ischemic disease (ISD) revealed no association with RAGE genotype. Further studies are required on other more prevalent genetic variants of RAGE and cardiovascular disease.

摘要

晚期糖基化终末产物受体(RAGE)在人类动脉粥样硬化斑块中的表达程度增强,并在斑块的易损区域与炎症和促氧化介质共定位。先前的研究强调了该受体编码基因中的一些变体,包括RAGE配体结合域内第82位氨基酸处的甘氨酸(Gly)到丝氨酸(Ser)的替换。与常见的RAGE Gly82等位基因相比,Ser82等位基因增强了配体结合亲和力,并增加了转染细胞和人类单核细胞中配体刺激的炎症介质生成。因此,在弗雷明汉后代研究(n = 1632)中检验Gly82Ser多态性患病率增加与心血管事件相关这一假设是合乎逻辑的。我们的分析显示,Gly82Ser RAGE多态性与糖尿病或非糖尿病受试者的心血管疾病发病率无任何关联(Gly82占96%,Ser82占4%)。对心血管疾病的具体表现进行分析,包括冠心病(CHD)、心血管疾病(CVD)、心肌梗死(MI)和缺血性疾病(ISD),结果显示与RAGE基因型无关联。需要对RAGE的其他更常见基因变体与心血管疾病进行进一步研究。

相似文献

1
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.在弗雷明汉后代研究中,晚期糖基化终末产物受体(RAGE)基因Gly82Ser多态性与心血管疾病无关。
Atherosclerosis. 2005 Oct;182(2):301-5. doi: 10.1016/j.atherosclerosis.2005.02.006.
2
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.晚期糖基化终末产物受体甘氨酸82丝氨酸多态性与类风湿关节炎患者心血管事件风险
Arthritis Res Ther. 2007;9(2):R39. doi: 10.1186/ar2175.
3
Association of RAGE (p.Gly82Ser) and MnSOD (p.Val16Ala) polymorphisms with diabetic retinopathy in T2DM patients from north India.印度北部2型糖尿病患者中晚期糖基化终末产物受体(p.Gly82Ser)和锰超氧化物歧化酶(p.Val16Ala)基因多态性与糖尿病视网膜病变的相关性
Diabetes Res Clin Pract. 2014 Apr;104(1):155-62. doi: 10.1016/j.diabres.2013.12.059. Epub 2014 Jan 9.
4
Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.晚期糖基化终末产物受体(RAGE)基因中Gly82Ser多态性与非糖尿病和非肥胖韩国人可溶性RAGE循环水平及炎症标志物的关联。
Metabolism. 2007 Feb;56(2):199-205. doi: 10.1016/j.metabol.2006.09.013.
5
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.晚期糖基化终产物受体(RAGE)多态性与系统性红斑狼疮及狼疮性肾炎疾病严重程度相关。
Lupus. 2012 Aug;21(9):959-68. doi: 10.1177/0961203312444495. Epub 2012 Apr 18.
6
[Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population].[晚期糖基化终末产物受体基因Gly82Ser多态性与中国2型糖尿病患者的相关性]
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Feb;27(2):219-22.
7
The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.晚期糖基化终末产物(RAGE)-374T/A和Gly82Ser变体以及可溶性RAGE水平对儿童肥胖的影响。
Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(5):9-14.
8
The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.晚期糖基化终产物受体(RAGE)基因启动子的-374A等位基因是2型糖尿病患者心血管病变的保护因素。
Clin Chem Lab Med. 2007;45(10):1268-72. doi: 10.1515/CCLM.2007.273.
9
Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.斑块状银屑病中晚期糖基化终末产物受体(RAGE)的基因多态性(G82S、1704G/T、2184A/G和2245G/A)
Arch Dermatol Res. 2002 May;294(3):127-30. doi: 10.1007/s00403-002-0301-7. Epub 2002 Apr 9.
10
Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?怒基因 GLY82 丝氨酸多态性与土耳其糖尿病和非糖尿病合并冠心病患者之间是否存在关联?
Mol Biol Rep. 2012 Apr;39(4):4423-8. doi: 10.1007/s11033-011-1230-3. Epub 2011 Sep 25.

引用本文的文献

1
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.晚期糖基化终产物受体 Gly82Ser 多态性增加了普通人群发生冠心病事件的风险。
Sci Rep. 2024 May 21;14(1):11567. doi: 10.1038/s41598-024-62385-5.
2
Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study.吡格列酮或格列美脲联合二甲双胍抗糖尿病治疗对 AGE-RAGE 轴的影响:一项随机前瞻性研究。
Front Endocrinol (Lausanne). 2023 Aug 11;14:1163554. doi: 10.3389/fendo.2023.1163554. eCollection 2023.
3
Association of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.
晚期糖基化终末产物受体(RAGE)基因Gly82Ser多态性与冠状动脉疾病及缺血性脑卒中的关联:一项系统评价与荟萃分析
Medicine (Baltimore). 2016 Dec;95(49):e5593. doi: 10.1097/MD.0000000000005593.
4
The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus.晚期糖基化终末产物受体驱动1型糖尿病中的T细胞存活和炎症反应。
J Immunol. 2016 Oct 15;197(8):3076-3085. doi: 10.4049/jimmunol.1600197. Epub 2016 Sep 21.
5
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.绝经后女性中晚期糖基化终末产物与心血管疾病的关系
Reprod Sci. 2015 Jul;22(7):774-82. doi: 10.1177/1933719114549845. Epub 2014 Sep 16.
6
Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease.晚期糖基化终产物受体基因多态性与冠心病的关系。
Mol Biol Rep. 2013 Nov;40(11):6097-105. doi: 10.1007/s11033-013-2721-1.
7
Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: a meta-analysis.四种 AGER 及其循环形式的遗传多态性与冠心病的关联:一项荟萃分析。
PLoS One. 2013 Jul 24;8(7):e70834. doi: 10.1371/journal.pone.0070834. Print 2013.
8
Meta-analysis of RAGE gene polymorphism and coronary heart disease risk.Meta 分析 RAGE 基因多态性与冠心病风险的关系。
PLoS One. 2012;7(12):e50790. doi: 10.1371/journal.pone.0050790. Epub 2012 Dec 6.
9
Genetic pathways of vascular calcification.血管钙化的遗传途径。
Trends Cardiovasc Med. 2012 May;22(4):93-8. doi: 10.1016/j.tcm.2012.07.002.
10
RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.人类 T 细胞中的 RAGE 表达:环境因素与适应性免疫反应之间的联系。
PLoS One. 2012;7(4):e34698. doi: 10.1371/journal.pone.0034698. Epub 2012 Apr 11.